Reviva Pharmaceuticals Q3 EPS $(0.12)

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.12) per share.

byBenzinga Newsdesk

November 15, 2021

1 minute read

Reviva Pharmaceuticals (NASDAQ:RVPH) reported quarterly losses of $(0.12) per share.

EXCLUSIVE: Sportradar CEO Highlights ‘Enormous’ Opportunity Ahead

By Adam Eckert

Today, 2:46 AM

Sports data company Sportradar Group AG (NASDAQ: SRAD) reported strong financial results Wednesday, showing approximately 40% top-line growth year-over-year — but it doesn't stop there.

SRAD

Earnings

How To Attend CBAK Energy Technology Q4 2021 Earnings Conference Call

By Benzinga Insights

Today, 2:46 AM

CBAK Energy Technology (NASDAQ:CBAT) will host a conference call at 08:00 AM ET on April 14, 2022, to discuss Q4 2021 earnings results. How to Attend CBAK Energy Technology (CBAT) Conference Call Follow this link to access the live webcast.

CBAT

Silicom Q1 EPS $0.44 Beats $0.41 Estimate, Sales $32.10M Beat $31.90M Estimate

By Benzinga Newsdesk

Today, 2:46 AM

Silicom (NASDAQ:SILC) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.41 by 7.32 percent. This is a 4.76 percent increase over earnings of $0.42 per share from the same

SILC

Here’s How Much You Would Have Made Owning Shopify Stock In The Last 5 Years

By Benzinga Insights

Today, 2:46 AM

Shopify (NYSE:SHOP) has outperformed the market over the past 5 years by 11.03% on an annualized basis producing an average annual return of 18.32%. Currently, Shopify has a market capitalization of $34.35 billion.

SHOP

Reviva Pharmaceuticals Q3 EPS $(0.12)

Related Posts

EXCLUSIVE: Sportradar CEO Highlights ‘Enormous’ Opportunity Ahead

How To Attend CBAK Energy Technology Q4 2021 Earnings Conference Call

Silicom Q1 EPS $0.44 Beats $0.41 Estimate, Sales $32.10M Beat $31.90M Estimate

Here’s How Much You Would Have Made Owning Shopify Stock In The Last 5 Years